Matrine inhibits proliferation and induces apoptosis via BID-mediated mitochondrial pathway in esophageal cancer cells

Molecular Biology Reports

Volumn 41, Issue 5, 2014, Pages 3009-3020

  Wang, Qiao ^a   Du, Haoxin ^b   Geng, Guojun ^b   Zhou, Huan ^a   Xu, Minying ^a   Cao, Hanwei ^a   Zhang, Bing ^a   Song, Gang ^a   Hu, Tianhui ^a  

^a XIAMEN UNIVERSITY   (China)

^b FUJIAN NORMAL UNIVERSITY   (China)

Author keywords

AIF; Apoptosis; BCL 2 BAX; BID; Esophageal cancer; Matrine; PARP

Indexed keywords

ALKALOID; ANTINEOPLASTIC AGENT; CASPASE 8; CASPASE 9; CYTOCHROME C; MATRINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN BID; QUINOLIZINE DERIVATIVE;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; ESOPHAGUS TUMOR; HUMAN; MALE; METABOLISM; MITOCHONDRION; MOUSE; PATHOLOGY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR VOLUME;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASE 8; CASPASE 9; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOCHROMES C; DISEASE MODELS, ANIMAL; ESOPHAGEAL NEOPLASMS; HUMANS; MALE; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; QUINOLIZINES; SIGNAL TRANSDUCTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84905702327     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3160-3     Document Type: Article

References (43)

1. Hu Y, Correa AM, Hoque A, Guan B, Ye F et al (2011) Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 128:132-143
2. Blot WJ (1994) Esophageal cancer trends and risk factors. Semin Oncol 21:403-410
3. Chen X, Yang CS (2001) Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 22:1119-1129 (Pubitemid 32737325)
4. Li Y, Wang B, Zhou C, Bi Y (2007) Matrine induces apoptosis in angiotensin II-stimulated hyperplasia of cardiac fibroblasts: effects on Bcl-2/Bax expression and caspase-3 activation. Basic Clin Pharmacol Toxicol 101:1-8 (Pubitemid 46934645)
5. Tao JY, Zheng GH, Zhao L, Huang ZJ, Zhang QG et al (2009) The anti-hyperlipidemia activities of six herbs before and after fermentation with white rot fungi. J Chin Pharm Sci 18:136-140
6. Long Y, Lin XT, Zeng KL, Zhang L (2004) Efficacy of intramuscular matrine in the treatment of chronic hepatitis B. Hepatobiliary Pancreat Dis Int 3:69-72 (Pubitemid 38256128)
7. Zhang JP, Zhang M, Jin C, Zhou B, Xie WF et al (2001) Matrine inhibits production and actions of fibrogenic cytokines released by mouse peritoneal macrophages. Acta Pharmacol Sin 22:765-768 (Pubitemid 32772425)
8. Zhu XH, Qiu YD, Shi MK, Wu B, Zheng XG et al (2003) Effect of matrine on cold ischemia and reperfusion injury of sinusoidal endothelial cells in rat orthotopic liver transplantation. Acta Pharmacol Sin 24:169-174
9. Zhang LP, Jiang JK, Tam JW, Zhang Y, Liu XS et al (2001) Effects of Matrine on proliferation and differentiation in K-562 cells. Leuk Res 25:793-800 (Pubitemid 32734092)
10. Hu MJ, Zeng H, Wu YL, Zhang YP, Zhang S et al (2005) Synergistic effects of matrine and 5-fluorouracil on tumor growth of the implanted gastric cancer in nude mice. Chin J Dig Dis 6:68-71 (Pubitemid 40936488)
11. Liu XY, Fang H, Yang ZG, Wang XY, Ruan LM et al (2008) Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro. Int J Dermatol 47:448-456 (Pubitemid 351560308)
12. Ma L, Wen S, Zhan Y, He Y, Liu X et al (2008) Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med 74:245-251 (Pubitemid 351449946)
13. Chae S, Kang KA, Chang WY, Kim MJ, Lee SJ et al (2009) Effect of compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation in human lung cancer cells in vitro and in vivo. J Agric Food Chem 57:5777-5782
14. Liu T, Song Y, Chen H, Pan S, Sun X (2010) Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo. Biol Pharm Bull 33:1740-1745
15. Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ (1996) BID: a novel BH3 domain-only death agonist. Genes Dev 10:2859-2869 (Pubitemid 26394246)
16. Yin XM (2006) Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 369:7-19
17. Fadeel B, Orrenius S (2005) Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 258:479-517 (Pubitemid 41705391)
18. Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342-348 (Pubitemid 32467043)
19. Wang C, Youle RJ (2009) The role of mitochondria in apoptosis. Annu Rev Genet 43:95-118
20. Song G, Chen GG, Chau DK, Miao J, Lai PB (2008) Bid exhibits S phase checkpoint activation and plays a pro-apoptotic role in response to etoposide-induced DNA damage in hepatocellular carcinoma cells. Apoptosis 13:693-701
21. Song G, Chen GG, Hu T, Lai PB (2010) Bid stands at the crossroad of stress-response pathways. Curr Cancer Drug Targets 10:584-592
22. Chen H, Sun B, Pan S, Jiang H, Sun X (2009) Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo. Anticancer Drugs 20:131-140
23. Dorsey JF, Jove R, Kraker AJ, Wu J (2000) The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells. Cancer Res 60:3127-3131 (Pubitemid 30407904)
24. van de Donk NW, Kamphuis MM, Lokhorst HM, Bloem AC (2002) The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells. Leukemia 16:1362-1371
25. Peng CY, Jiang J, Zheng HT, Liu XS (2010) Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines. Leuk Lymphoma 51:297-303
26. Song G, Mao YB, Cai QF, Yao LM, Ouyang GL et al (2005) Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Braz J Med Biol Res 38:1791-1798 (Pubitemid 43078608)
27. Wu M, Zhao JK, Zhang ZF, Han RQ, Yang J et al (2011) Smoking and alcohol drinking increased the risk of esophageal cancer among Chinese men but not women in a high-risk population. Cancer Causes Control 22:649-657
28. Pink RC, Bailey TA, Iputo JE, Sammon AM, Woodman AC et al (2011) Molecular basis for maize as a risk factor for esophageal cancer in a South African population via a prostaglandin E2 positive feedback mechanism. Nutr Cancer 63:714-721
29. Montesano R, Hollstein M, Hainaut P (1996) Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 69:225-235 (Pubitemid 26233303)
30. Hu C, Song G, Zhang B, Liu Z, Chen R et al (2012) Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway. J Cell Mol Med 16:96-106
31. Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ et al (2012) Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother Pharmacol 69:317-331
32. Chang C, Zhu YQ, Mei JJ, Liu SQ, Luo J (2010) Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells. J Exp Clin Cancer Res 29:145
33. Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647-656 (Pubitemid 37328916)
34. Brunelle JK, Letai A (2009) Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 122:437-441
35. Leibowitz B, Yu J (2010) Mitochondrial signaling in cell death via the Bcl-2 family. Cancer Biol Ther 9:417-422
36. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ et al (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3:1089-1095 (Pubitemid 27444449)
37. Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA (1997) Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 17:1143-1151 (Pubitemid 27514738)
38. Zhang J, Dawson VL, Dawson TM, Snyder SH (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263:687-689 (Pubitemid 24076297)
39. Smulson ME, Simbulan-Rosenthal CM, Boulares AH, Yakovlev A, Stoica B et al (2000) Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1. Adv Enzyme Regul 40:183-215 (Pubitemid 30412535)
40. Soldatenkov VA, Chasovskikh S, Potaman VN, Trofimova I, Smulson ME et al (2002) Transcriptional repression by binding of poly(ADP-ribose) polymerase to promoter sequences. J Biol Chem 277:665-670 (Pubitemid 34952105)
41. Hong SJ, Dawson TM, Dawson VL (2004) Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci 25:259-264 (Pubitemid 38553828)
42. Parreno M, Casanova I, Cespedes MV, Vaque JP, Pavon MA et al (2008) Bobel-24 and derivatives induce caspase-independent death in pancreatic cancer regardless of apoptotic resistance. Cancer Res 68:6313-6323
43. Mukhopadhyay P, Horvath B, Kechrid M, Tanchian G, Rajesh M et al (2011) Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury. Free Radic Biol Med 51:1774-1788